Punn Rajesh, Falkensammer Christine B, Blinder Joshua J, Fifer Carlen G, Thorsson Thor, Perens Gregory, Federman Myke, Gupta Punkaj, Best Thomas, Arya Bhawna, Chan Titus, Sherman-Levine Sara, Smith Shea N, Axelrod David M, Roth Stephen J, Tacy Theresa A
Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, Lucile Packard Children's Hospital Stanford, Palo Alto, California.
Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
J Am Soc Echocardiogr. 2023 Feb;36(2):233-241. doi: 10.1016/j.echo.2022.10.005. Epub 2022 Oct 10.
Venoarterial extracorporeal membrane oxygenation (ECMO) supports patients with advanced cardiac dysfunction; however, mortality occurs in a significant subset of patients. The authors performed a multicenter, prospective study to determine hemodynamic and echocardiographic predictors of mortality in children placed on ECMO for cardiac support.
Over 8 years, six heart centers prospectively assessed echocardiographic and hemodynamic variables on full and minimum ECMO flow. Sixty-three patients were enrolled, ranging in age from 1 day to 16 years. Hemodynamic measurements included heart rate, vasoactive inotropic score, arteriovenous oxygen difference, pulse pressure, and lactate. Echocardiographic variables included shortening fraction, ejection fraction (EF), right ventricular fractional area change, outflow tract Doppler-derived stroke distance (velocity-time integral [VTI]), and degree of atrioventricular valve regurgitation. Patients were stratified into two groups: those who were able to wean within 48 hours of assessment and survived without ventricular assist devices or orthotopic heart transplantation (successful wean group) and those with unsuccessful weaning. For each patient, variables were compared between full and minimum ECMO flow for each group.
Thirty-eight patients (60%) formed the unsuccessful group (two with ventricular assist devices, four with orthotopic heart transplantation, 24 deaths), and 25 constituted the successful wean group. At minimum flow, higher EF (53 ± 16% vs 40 ± 20%, P = .0094), less mitral regurgitation (0.8 ± 0.9 vs 1.4 ± 0.9, P = .0329), and lower central venous pressure (12.0 ± 3.9 vs 14.7 ± 5.4 mm Hg), along with higher VTI (9.0 ± 2.9 vs 6.8 ± 3.7 cm, P = .0154), correlated successful weaning. A longer duration of ECMO (8 vs 5 days, P < .0002) was associated with unsuccessful weaning. Multivariate logistic regression predicted minimum-flow EF and VTI to independently predict successful weaning with cutoff values by receiver operating characteristic analysis of EF > 41% (area under the curve, 0.712; P = .0005) and VTI > 7.9 cm (area under the curve, 0.729; P = .0010).
Diminished VTI or EF during ECMO weaning predicts the need for orthotopic heart transplantation or ventricular assist device support or death in children on ECMO for cardiac dysfunction. Increased postwean central venous pressure or mitral regurgitation along with a prolonged ECMO course also predicted these adverse outcomes. These measurements should be used to help discriminate which patients will require alternative methods of circulatory support for survival.
静脉 - 动脉体外膜肺氧合(ECMO)用于支持患有严重心功能不全的患者;然而,相当一部分患者会死亡。作者进行了一项多中心前瞻性研究,以确定接受ECMO心脏支持的儿童患者死亡的血流动力学和超声心动图预测因素。
在8年时间里,6个心脏中心前瞻性地评估了在ECMO全流量和最小流量时的超声心动图及血流动力学变量。共纳入63例患者,年龄从1天至16岁。血流动力学测量包括心率、血管活性药物评分、动静脉血氧差、脉压和乳酸。超声心动图变量包括缩短分数、射血分数(EF)、右心室面积变化分数、流出道多普勒衍生的每搏距离(速度 - 时间积分[VTI])以及房室瓣反流程度。患者被分为两组:在评估后48小时内能够撤机且未使用心室辅助装置或原位心脏移植而存活的患者(成功撤机组)和撤机失败的患者。对于每组中的每位患者,比较了全流量和最小流量时的变量。
38例患者(60%)组成了失败组(2例使用心室辅助装置,4例接受原位心脏移植,24例死亡),25例组成了成功撤机组。在最小流量时,较高的EF(53±16%对40±20%,P = 0.0094)、较少的二尖瓣反流(0.8±0.9对1.4±0.9,P = 0.0329)、较低的中心静脉压(12.0±3.9对14.7±5.4 mmHg)以及较高的VTI(9.0±2.9对6.8±3.7 cm,P = 0.0154)与成功撤机相关。ECMO持续时间较长(8天对5天,P < 0.0002)与撤机失败相关。多因素逻辑回归预测最小流量时的EF和VTI可独立预测成功撤机,通过受试者工作特征分析得出EF > 41%(曲线下面积,0.712;P = 0.0005)和VTI > 7.9 cm(曲线下面积,0.729;P = 0.0010)为截断值。
在ECMO撤机过程中VTI或EF降低预示着接受ECMO治疗的心功能不全儿童患者需要进行原位心脏移植或心室辅助装置支持或死亡。撤机后中心静脉压升高或二尖瓣反流增加以及ECMO疗程延长也预示着这些不良结局。这些测量结果应用于帮助鉴别哪些患者需要替代循环支持方法以存活。